Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Aiforia Technologies

3.34

 

EUR

 

-0.6 %

2,006 following

AIFORIA

First North Finland

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Investor consensus
Compare
-0.6%
-1.76%
-4.57%
-9.24%
-4.84%
-26.11%
-13.25%
-
-33.99%

Aiforia Technologies equips pathologists and researchers in preclinical and clinical laboratories with software to translate images into discoveries, decisions and diagnoses. The company's products and services are used for medical image analysis, across a variety of areas from oncology to neuroscience. Aiforia Technologies is headquartered in Finland.

Read more
Market cap
105.57M EUR
Turnover
89.22K EUR
P/E (adj.) (25e)
-8.94
EV/EBIT (adj.) (25e)
-8.73
P/B (25e)
7.41
EV/S (25e)
22.07
Dividend yield-% (25e)
-
Coverage
Recommendation
Accumulate
Target price
4.20 EUR
Updated
23.04.2025
Disclaimer
Frans-Mikael Rostedt
Antti Luiro
Antti Luiro, Frans-Mikael Rostedt
Show more
Latest research

Latest analysis report

Released: 24.04.2025

Latest extensive report

Released: 24.04.2025

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
28.8
2025

Interim report Q2'25

Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types
Press release9 hours ago

Aiforia to publish January–June 2025 Half-year Financial Report on August 28, 2025

Aiforia Technologies
Regulatory press release11 hours ago

Change in Aiforia Technologies Plc’s Management Team

Aiforia Technologies
Aiforia, Webcast, Q2'25
Webcast8/28/2025, 10:00 AM

Aiforia, Webcast, Q2'25

Aiforia Technologies

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Aiforia establishes a subsidiary in France
Analyst Comment7/10/2025, 7:20 AM by
Frans-Mikael Rostedt, Antti Luiro

Aiforia establishes a subsidiary in France

Aiforia has had a sales organization in France since 2023, and the newly formed subsidiary will strengthen the company's local presence and support its growing business in the country.

Aiforia Technologies
Press release7/9/2025, 6:00 AM

Aiforia establishes a subsidiary in France to strengthen its position in the European market

Aiforia Technologies
Regulatory press release7/2/2025, 2:00 PM

Aiforia Technologies Plc – Managers’ Transactions – Joseph Bernardo

Aiforia Technologies
Regulatory press release6/25/2025, 6:00 AM

Aiforia Technologies Plc: Share subscriptions based on stock options 2016 B, 2020 I ja 2021 I

Aiforia Technologies
Regulatory press release6/24/2025, 3:30 PM

The Board of Directors of Aiforia Technologies Plc decided on new Stock Option Plan

Aiforia Technologies
Analyst Comment6/24/2025, 10:49 AM by
Antti Luiro, Frans-Mikael Rostedt

Aiforia's product portfolio expands with new CE-IVD approved solution for breast cancer diagnostics

This solution is Aiforia's ninth to receive CE-IVD approval in Europe. However, unlike previous approvals, the solution includes five separate AI models, so the approval significantly expands the company's product portfolio (8 models + 1 viewer -> 13 models + 1 viewer). The approval increases the potential scale of the company's new customer agreements and also enables larger expansions for existing customers.

Aiforia Technologies
Press release6/24/2025, 6:00 AM

Aiforia releases a new CE-IVD-marked clinical AI solution for breast cancer diagnostics

Aiforia Technologies
Aiforia Technologies: Valuable reference in France10:18
Video6/17/2025, 1:34 PM by
Antti Luiro

Aiforia Technologies: Valuable reference in France

Aiforia’s CEO Jukka Tapaninen provides an update on what is currently happening in the company in an interview with analyst Antti Luiro. Topics include new customers, ongoing negotiations, and expansion to new models for existing customers.

Aiforia Technologies
Regulatory press release5/30/2025, 3:00 PM

Aiforia Technologies Plc: Disclosure under Chapter 9 Section 10 of the Securities Market Act - Sto-Rahoitus Oy’s holding in Aiforia Technologies Plc

Aiforia Technologies
Regulatory press release5/30/2025, 9:00 AM

Aiforia Technologies Plc – Managers’ Transactions – Tuomas Tenkanen

Aiforia Technologies
Regulatory press release5/30/2025, 8:00 AM

Aiforia Technologies Plc – Managers’ Transactions – Jukka Tapaninen

Aiforia Technologies
Regulatory press release5/29/2025, 8:30 AM

Aiforia Technologies Plc: Disclosure under Chapter 9 Section 10 of the Securities Market Act - Ascend Tapio Sarl’s holding in Aiforia Technologies Plc

Aiforia Technologies
Regulatory press release5/28/2025, 1:00 PM

A total of 2,502,187 new shares in Aiforia Technologies Plc registered with the Trade Register

Aiforia Technologies
Analyst Comment5/28/2025, 6:22 AM by
Antti Luiro, Frans-Mikael Rostedt

Aiforia raised 8 MEUR in an expected directed issue

The issue was fully expected, as we believe the company’s implementation of its growth strategy requires additional funding to be collected this year. The terms (EUR 3.2 per share, gross proceeds of some 8 MEUR) were quite well in line with our expectations.

Aiforia Technologies
Regulatory press release5/27/2025, 8:30 PM

Inside information: Aiforia Technologies Plc successfully completes a directed share issue raising EUR 8 million

Aiforia Technologies
Regulatory press release5/27/2025, 3:31 PM

Inside information: Aiforia Technologies Plc intends to carry out a directed share issue by means of an accelerated bookbuilding proces

Aiforia Technologies
Press release5/26/2025, 7:00 AM

Aiforia appoints Richard Doughty as Medical Director

Aiforia Technologies
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.